Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysis
Abstract Bispecific antibodies (BiTEs) have transformed the therapeutic landscape of relapsed/refractory multiple myeloma (RRMM), offering deep and durable responses even in heavily pretreated patients. However, their use carries substantial infectious risk due to immunosuppression, particularly hyp...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer
2026-04-01
|
| Serija: | Annals of Hematology |
| Teme: | |
| Online dostop: | https://doi.org/10.1007/s00277-026-07026-9 |
| Oznake: |
Brez oznak, prvi označite!
|